Therefore, we aim to introduce the current knowledge of APP modifications and trafficking, review their important roles in APP processing and Aβ generation, and discuss the effect of aberrant post-translational modifications and trafficking on Aβ generation, which may provide novel strategies for drug development in AD. This evidence concerns the gene APP and Alzheimer disease.